Top Five Pharma CEO Paypackets Total More Than $100M
June 8, 2015.
Looking at aggregated data from The New York Times, which used filings from the Securities and Exchange Commission to compute CEO compensation, The Motley Fool, noting that four of the highest-paid CEOs in pharma saw their pay increase last year.
Motley Fool lists the five best-paid pharma CEOs as
- Lamverto Andriotti, BMS: $26.1 million
- Kenneth Frazier, Merck: $21.4 million
- Alex Gorksy, J&J: 20.4 million
- Ian Read, Pfizer: $18 million
- Richard Gonzalez, AbbVie: $17 million.
The key question, the reports asks, is "Are these pay package increases merited?"
Recent Videos
Related Content
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025Article
As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
